However, CS-E treatment of breast cancer cells plated on type 1 collagen-coated membranes was now unable to interfere with cell migration (Figure 3D), demonstrating that an exogenous Collagen matrix could overcome the CS-E-mediated negative regulation of Col1a1 expression and cell migration. Here, COL1A1 is linked to breast carcinoma.